Atopic Dermatitis
Conditions
Interventions
Qing peng cream group:wet wrap therapy with Qing peng
halometasone cream:wet wrap therapy with halometasone
Sponsors
Department of Dermatology, Beijing Friendship Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. aged from >18 years male and female; 2. Clinically Diagnosed with AD according to the Williams criteria and had a SCORing Atopic Dermatitis (SCORAD) score =50, IGA=3.
Exclusion criteria
Exclusion criteria: 1. with severe disease in the liver, kidney, and/or blood; with autoimmune diseases, chronic serious infection, diabetes, mental diseases; 2. with the malignant tumor or other serious diseases that may compromise the accuracy of efficacy evaluation for the study drug; 3. rash on face, skin folds such as anus, vulva; 4. other reasons that researchers think that should not be selected.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Scoring Atopic Dermatitis (SCORAD) score;visual analogue scale (VAS);investigator’s global assessment (IGA) score;dermatology life quality index (DLQI) score;serum cortisol (COR);IgE;IL-4, IL-5, IL-13, IFN-?, IL-1, IL-17, IL-10, TGF-ß, OX40, CD39; | — |
Countries
China
Contacts
Public ContactLi Linfeng
Department of Dermatology, Beijing Friendship Hospital, Capital Medical University
Outcome results
None listed